Search - tctmd.com

Displaying 121 - 140 of 263

Sort: Relevancy | Date

Could Copper Chelation Benefit HFrEF? TRACER-HF Offers Mixed Clues

Shelley Wood

May 25, 2023

News Conference News ESC Heart Failure 2023

Loop Diuretics Are Heavily Prescribed Outside of HF: That’s a Problem

Shelley Wood

May 23, 2023

News Conference News ESC Heart Failure 2023

Amyloid Removal Looks Possible in ATTR Cardiomyopathy Imaging Trial

Shelley Wood

May 23, 2023

News Opinion CV Team Dispatch

May 2023 News Roundup

L.A. McKeown

May 01, 2023

News Daily News

Drugs to Tweak RAAS Response No Help in Acute COVID-19, RCTs Show

Caitlin E. Cox

April 19, 2023

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Opinion CV Team Dispatch

April 2023 News Roundup

L.A. McKeown

April 01, 2023

News Daily News

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Michael O'Riordan

March 29, 2023

News Conference News THT 2023

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Yael L. Maxwell

March 22, 2023

News Opinion CV Team Dispatch

March 2023 News Roundup

L.A. McKeown

March 15, 2023

News Conference News ACC 2023

IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF

L.A. McKeown

March 14, 2023

News Conference News ACC 2023

STELLAR, ‘Impressive’ Results With Novel Drug Sotatercept in PAH

Shelley Wood

March 06, 2023

News Daily News

Top Heart Failure News of 2022

Shelley Wood

January 04, 2023

News Features

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

Shelley Wood

December 20, 2022

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

News Conference News AHA 2022

EMPA-KIDNEY: Empagliflozin a ‘Win’ for Patients With CKD

Todd Neale

November 06, 2022

News Conference News AHA 2022

IRONMAN Misses but Lends Support to IV Iron Repletion in HF

Shelley Wood

November 05, 2022

News Conference News AHA 2022

TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF

Todd Neale

November 05, 2022

News Conference News AHA 2022

Novel Intervention to Increase GDMT in HF Exploits Noncardiac Admissions

Yael L. Maxwell

November 01, 2022

Advertisement

Could Copper Chelation Benefit HFrEF? TRACER-HF Offers Mixed Clues

Loop Diuretics Are Heavily Prescribed Outside of HF: That’s a Problem

Amyloid Removal Looks Possible in ATTR Cardiomyopathy Imaging Trial

May 2023 News Roundup

Drugs to Tweak RAAS Response No Help in Acute COVID-19, RCTs Show

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

April 2023 News Roundup

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

March 2023 News Roundup

IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF

STELLAR, ‘Impressive’ Results With Novel Drug Sotatercept in PAH

Top Heart Failure News of 2022

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

EMPA-KIDNEY: Empagliflozin a ‘Win’ for Patients With CKD

IRONMAN Misses but Lends Support to IV Iron Repletion in HF

TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF

Novel Intervention to Increase GDMT in HF Exploits Noncardiac Admissions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content